suberoyl bis-hydroxamic acid has been researched along with Carcinoma, Large Cell in 1 studies
suberoyl bis-hydroxamic acid: antineoplastic, Histone Deacetylase inhibitor
Carcinoma, Large Cell: A tumor of undifferentiated (anaplastic) cells of large size. It is usually bronchogenic. (From Dorland, 27th ed)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zhao, Y | 1 |
| Yu, D | 1 |
| Wu, H | 1 |
| Liu, H | 1 |
| Zhou, H | 1 |
| Gu, R | 1 |
| Zhang, R | 1 |
| Zhang, S | 1 |
| Wu, G | 1 |
1 other study available for suberoyl bis-hydroxamic acid and Carcinoma, Large Cell
| Article | Year |
|---|---|
Anticancer activity of SAHA, a potent histone deacetylase inhibitor, in NCI-H460 human large-cell lung carcinoma cells in vitro and in vivo.
Topics: Animals; Antineoplastic Agents; Apoptosis; Blotting, Western; Carcinoma, Large Cell; Carcinoma, Non- | 2014 |